N‑methyl‑N‑nitrosourea‑induced cerebellar hypoplasia in rats: Effect of arachidonic acid supplementation during the gestational, lactational and post‑weaning periods

Yoshizawa,Katsuhiko; Emoto,Yuko; Kinoshita,Yuichi; Yuri,Takashi; Tsubura,Airo

doi:10.3892/etm.2013.1219

N‑methyl‑N‑nitrosourea‑induced cerebellar hypoplasia in rats: Effect of arachidonic acid supplementation during the gestational, lactational and post‑weaning periods

Authors:
- Katsuhiko Yoshizawa
- Yuko Emoto
- Yuichi Kinoshita
- Takashi Yuri
- Airo Tsubura
View Affiliations

Affiliations: Department of Pathology II, Kansai Medical University, Hirakata, Osaka 573‑1010, Japan
Published online on: July 12, 2013 https://doi.org/10.3892/etm.2013.1219
Pages: 627-634

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

Arachidonic acid (AA) is a fatty acid that is important for visual and brain development and is commonly added as a functional food ingredient to commercial infant formulas worldwide. However, few studies have examined whether AA supplementation during neonatal life has an effect on neuronal abnormalities. In the present study, the effect of dietary AA supplementation in dams during gestation and lactation was investigated by examining N‑methyl‑N‑nitrosourea (MNU)‑induced cerebellar hypoplasia in young Lewis rats. Dams were fed a 2.0% AA diet or a basal diet (<0.01% AA). At birth (postnatal day 0), male and female pups received a single intraperitoneal injection of 35 mg/kg MNU or vehicle. Brain weights were measured and a morphological analysis of macroscopic and histological specimens was conducted after 7, 14, 21, 28 and 60 days. Irrespective of whether the rats had been fed an AA diet, the brain weights of the MNU‑treated rats, particularly the weights of the cerebellum, were decreased compared with those of the MNU‑untreated rats from the 14th day following the MNU injection. Macroscopic reductions in the cerebellar length and/or width and histologically observed reductions in cerebellar vertex height and/or cortex width were also detected in the MNU‑treated rats, irrespective of whether the rats had been fed with AA. Histopathologically, the MNU‑treated rats (irrespective of AA supplementation) exhibited disorganization of the cerebellar cortex and disarrangement of the cortical layers (loss and/or disturbance of the molecular, Purkinje and granular cell layers). There were no significant differences in any parameters among the MNU‑treated rats, irrespective of whether the rats had been fed an AA diet. In conclusion, an AA‑rich diet for dams during gestation and lactation did not modify MNU‑induced cerebellar hypoplasia in their offspring.

View Figures

View References

1	Biran V, Verney C and Ferriero DM: Perinatal cerebellar injury in human and animal models. Neurol Res Int. 2012:8589292012. View Article : Google Scholar : PubMed/NCBI
2	Safronova MM, Barbot C and Resendepereira J: Hipoplasias cerebelosas. Acta Med Port. 23:841–852. 2010.(In Portuguese).
3	Altman J: Morphological and behavioral markers of environmentally induced retardation of brain development: an animal model. Environ Health Perspect. 74:153–168. 1987. View Article : Google Scholar : PubMed/NCBI
4	Ogura H, Mikami T, Takamura N, Suzuki Y and Chiba T: Development of behavioral function of cerebellar hypoplasia rats as induced by cytosine arabinoside (ara-C). Nihon Yakurigaku Zasshi. 76:33–44. 1980.(In Japanese).
5	Ramaekers VT, Heimann G, Reul J, Thron A and Jaeken J: Genetic disorders and cerebellar structural abnormalities in childhood. Brain. 120:1739–1751. 1997. View Article : Google Scholar : PubMed/NCBI
6	Kodama M, Fujiyama F, Yamada S, Shiota K and Nagao T: Methylnitrosourea induces neural progenitor cell apoptosis and microcephaly in mouse embryos. Birt Defects Res B Dev Reprod Toxicol. 89:213–222. 2010.PubMed/NCBI
7	Kimura A, Yoshizawa K, Sasaki T, Uehara N, Kinoshita Y, Miki H, Yuri T, Uchida T and Tsubura A: N-methyl-N-nitrosourea-induced changes in epithelial rests of Malassez and the development of odontomas in rats. Exp Ther Med. 4:15–20. 2012.PubMed/NCBI
8	Tsubura A, Lai YC, Miki H, Sasaki T, Uehara N, Yuri T and Yoshizawa K: Animal models of N-methyl-N-nitrosourea-induced mammary cancer and retinal degeneration with special emphasis on therapeutic trials. In Vivo. 25:11–22. 2011.PubMed/NCBI
9	Yoshizawa K, Emoto Y, Kinoshita Y, Kimura A, Uehara N, Yuri T, Shikata N, Hamazaki T and Tsubura A: Arachidonic acid supplementation does not affect N-methyl-N-nitrosourea-induced renal preneoplastic lesions in young Lewis rats. Oncol Lett. 5:1112–1116. 2013.PubMed/NCBI
10	Yoshizawa K, Uehara N, Kimura A, Emoto Y, Kinoshita Y, Yuri T, Takada H, Moriguchi T, Hamazaki T and Tsubura A: Promoting effect of arachidonic acid supplementation on N-methyl-N-nitrosourea-induced pancreatic acinar cell hyperplasia in young Lewis rats. Oncol Lett. 5:76–82. 2013.PubMed/NCBI
11	Singla N and Dhawan DK: N-methyl-N-nitrosourea induced functional and structural alterations in mice brain - role of curcumin. Neurotox Res. 22:115–126. 2012. View Article : Google Scholar : PubMed/NCBI
12	Kleihues P and Patzschke K: Distribution of N-(¹⁴C) methyl-N-nitrosourea in the rat after its systemic administration. Z Krebsforsch. 75:193–200. 1971.(In German).
13	Shibutani M, Maekawa A, Okeda R, Mitsumori K, Imazawa T, Yoshiza J, Onodera H and Hayashi Y: An experimental model for anaplastic astrocytomas and glioblastoma using adult F344 rats and N-methyl-N-nitrosourea. Acta Pathol Jpn. 43:464–474. 1993.PubMed/NCBI
14	Becker K, Dosch J, Gregel CM, Martin BM and Kaina B: Targeted expression of human O⁶-methylguanine-DNA ethyl transferase (MGMT) in transgenic mice protects against tumor initiation in two-stage skin carcinogenesis. Cancer Res. 56:3244–3249. 1996.PubMed/NCBI
15	Kidney JK and Faustman EM: Modulation of nitrosourea toxicity in rodent embryonic cells by O6-benzylguanine, a depletory of O⁶-methylguanine-DNA methyltransferase. Toxicol Appl Pharmacol. 133:1–11. 1995. View Article : Google Scholar : PubMed/NCBI
16	Schleifer S and Tempel K: Formation and persistence of N⁷- and O⁶-methyl-guanine in DNA of chick embryo brain cells in ovo following administration of N-nitroso-N-methylurea. Zentralbl Veterinarmed A. 43:589–598. 1996.
17	Fujiyama F, Saito Y and Nagao T: Effects of prenatal exposure to methyl nitrosourea on the developing brains of mouse offspring. Congenit Anom (Tokyo). 47:A292007.
18	Fujimori K, Inoue K, Nakazawa K, Maekawa A, Shibutani M and Takanaka A: Neurochemical and histological analysis of motor dysfunction observed in rats with methylnitrosourea-induced experimental cerebellar hypoplasia. Neurochem Res. 17:223–231. 1992. View Article : Google Scholar
19	Smith SB, Brown CB, Wright ME and Yielding KL: Late-onset cerebellar degeneration in mice induced transplacentally by methylnitrosourea. Teratog Carcinog Mutagen. 7:449–463. 1987. View Article : Google Scholar : PubMed/NCBI
20	Smith SB, Cooke CB and Yielding KL: The antioxidant butylated hydrotoluene can retard cerebellar degeneration induced transplacentally by a single low dosage of N-methyl-N-nitrosourea. Teratog Carcinog Mutagen. 9:15–27. 1989. View Article : Google Scholar : PubMed/NCBI
21	Arterburn LM, Hall EB and Oken H: Distribution, interconversion, and dose response of n-3 fatty acids in humans. Am J Clin Nutr. 83(Suppl): 1467S–1476S. 2006.PubMed/NCBI
22	Semba RD: Essential fatty acids and visual development in infants. Handbook of Nutrition and Ophthalmology. Humana Press; New Jersey: pp. 415–441. 2007
23	Davis-Bruno K and Tassinari MS: Essential fatty acid supplementation of DHA and ARA and effects on neurodevelopment across animal species: a review of the literature. Birth Defects Res B Dev Reprod Toxicol. 92:240–250. 2012. View Article : Google Scholar : PubMed/NCBI
24	Saste MD, Carver JD, Stockard JE, Benford VJ, Chen LT and Phelps CP: Maternal diet fatty acid composition affects neurodevelopment in rat pups. J Nutr. 128:740–743. 1998.PubMed/NCBI
25	Maekawa M, Takashima N, Matsumata M, Ikegami S, Kontani M, Hara Y, Kawashima H, Owada Y, Kiso Y, Yoshikawa T, Inokuchi K and Osumi N: Arachidonic acid drives postnatal neurogenesis and elicits a beneficial effect on prepulse inhibition, a biological trait of psychiatric illnesses. PLoS ONE. 4:e50852009. View Article : Google Scholar : PubMed/NCBI
26	Osumi N: Fatty acid signal, neurogenesis, and psychiatric disorders. Nihon Shinkei Seishin Yakurigaku Zasshi. 30:141–148. 2010.(In Japanese).
27	Hoffman DR, Boettcher JA and Diersen-Schade DA: Toward optimizing vision and cognition in term infants by dietary docosahexaenoic and arachidonic acid supplementation: a review of randomized controlled trials. Prostaglandins Leukot Essent Fatty Acids. 81:151–158. 2009. View Article : Google Scholar : PubMed/NCBI
28	Uauy R, Hoffman DR, Peirano P, Birch DG and Birch EE: Essential fatty acids in visual and brain development. Lipids. 36:885–895. 2001. View Article : Google Scholar : PubMed/NCBI
29	Yoshizawa K, Nambu H, Yang J, Oishi Y, Senzaki H, Shikata N, Miki H and Tsubura A: Mechanisms of photoreceptor cell apoptosis induced by N-methyl-N-nitrosourea in Sprague-Dawley rats. Lab Invest. 79:1359–1367. 1999.PubMed/NCBI
30	Yoshizawa K and Tsubura A: Characteristics of N-methyl-N-nitrosourea-induced retinal degeneration in animals and application for the therapy of human retinitis pigmentosa. Nippon Ganka Gakkai Zasshi. 109:327–337. 2005.(In Japanese).
31	Yoshizawa K, Sasaki T, Kuro M, Uehara N, Takada H, Harauma A, Ohara N, Moriguchi T and Tsubura A: Arachidonic acid supplement during gestational, lactational and post-weaning periods prevents retinal degeneration induced in a rodent model. Br J Nutr. 109:1424–1432. 2013. View Article : Google Scholar
32	Bolon B, Garman R, Jensen K, Krinke G and Stuart B: A ‘best practices’ approach to neuropathologic assessment in developmental neurotoxicity testing - for today. Toxicol Pathol. 34:296–313. 2006.
33	Kaufmann W, Bolon B, Bradley A, Butt M, Czasch S, Garman RH, George C, Groters S, Krinke G, Little P, McKay J, Narama I, Rao D, Shibutani M and Sills R: Proliferative and nonproliferative lesions of the rat and mouse central and peripheral nervous systems. Toxicol Pathol. 40(Suppl): 87S–157S. 2012. View Article : Google Scholar : PubMed/NCBI
34	Rice D and Barone S Jr: Critical periods of vulnerability for the developing nervous system: evidence from humans and animal models. Environ Health Perspect. 108(Suppl 3): S511–S533. 2000. View Article : Google Scholar : PubMed/NCBI
35	Fujimori K, Sunouchi M, Inoue K, Nakadate M, Takanaka A and Omori Y: Cytotoxic effects of methylnitrosourea on developing brain. Neurochem Res. 8:193–206. 1983. View Article : Google Scholar : PubMed/NCBI
36	Report of the 28th session of the Codex Committee on Nutrition and Foods for Special Dietary Uses. Joint FAO/WHO Food Standards Programme, Codex Alimentarus Commission; 2007
37	Moriguchi T, Loewke J, Garrison M, Catalan JN and Salem N Jr: Reversal of docosahexaenoic acid deficiency in the rat brain, retina, liver, and serum. J Lipid Res. 42:419–427. 2001.PubMed/NCBI
38	Sakayori N, Maekawa M, Numayama-Tsuruta K, Katura T, Moriya T and Osumi N: Distinctive effects of arachidonic acid and docosahexaenoic acid on neural stem/progenitor cells. Genes Cells. 16:778–790. 2011. View Article : Google Scholar : PubMed/NCBI
39	Katsuki H and Okuda S: Arachidonic acid as a neurotoxic and neurotrophic substance. Prog Neurobiol. 46:607–636. 1995. View Article : Google Scholar : PubMed/NCBI
40	Kim HY, Akbar M and Kim KY: Inhibition of neuronal apoptosis by polyunsaturated fatty acids. J Mol Neurosci. 16:223–278. 2001. View Article : Google Scholar : PubMed/NCBI
41	Imai N, Kawabe M, Tamano S, Doi Y, Nakashima H, Suguro M, Numano T, Hara T, Hagiwara A, Furukawa F, Kaneda Y, Tateishi N, Fujii W, Kawashima H, Shibata H and Sakakibara Y: Arachidonate-enriched triglyceride oil does not promote tumor development in a rat medium-term multi-organ carcinogenesis model. Food Chem Toxicol. 50:2780–2791. 2012. View Article : Google Scholar : PubMed/NCBI